↓ Skip to main content

Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models

Overview of attention for article published in Clinical and Translational Oncology, November 2019
Altmetric Badge

Mentioned by

twitter
2 tweeters
Title
Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models
Published in
Clinical and Translational Oncology, November 2019
DOI 10.1007/s12094-019-02235-3
Pubmed ID
Authors

G. S. Shukla, S. C. Pero, Y. -J. Sun, L. Mei, F. Zhang, G. Sholler, D. N. Krag

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2019.
All research outputs
#11,151,475
of 14,051,752 outputs
Outputs from Clinical and Translational Oncology
#451
of 720 outputs
Outputs of similar age
#179,611
of 251,328 outputs
Outputs of similar age from Clinical and Translational Oncology
#14
of 20 outputs
Altmetric has tracked 14,051,752 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 720 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,328 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.